NYT
How GLP-1s Feed Our Sick Culture
Wednesday, July 8, 2026
This appears to be an opinion piece rather than a factual news report. GLP-1 receptor agonist medications are a class of drugs approved by the FDA for diabetes management and weight loss treatment, with products including semaglutide and tirzepatide.
Original reporting: https://www.nytimes.com/2026/07/08/opinion/glp1-ozempic-caroline-calloway.html